The Cannabis Wholesale Collapse Is Real — But It’s Not Happening Everywhere at Once

Wholesale cannabis prices are falling nationally, but the headline number masks a patchwork of regional stories — some markets are still holding, others are in freefall. Understanding which is which now matters more than ever for operators making capital decisions.

The Cannabis Wholesale Collapse Is Real — But It’s Not Happening Everywhere at Once
Illustrative Image | AI Generated

The Cannabis Wholesale Collapse Is Real — But It’s Not Happening Everywhere at Once

The national wholesale cannabis price trend is down. That much is not in dispute. But new analysis of wholesale data across U.S. markets makes the case that the aggregate picture — the one that gets cited in earnings calls and investor decks — may be actively misleading operators who rely on it to make cultivation, expansion, and pricing decisions.

The national trend is down. Your market may disagree. That distinction is turning out to matter quite a lot.

A National Problem With Local Exceptions

Wholesale cannabis prices across the United States have been compressing for the better part of three years. The proximate causes are well understood: an oversupply boom in early-legalization markets, proliferating cultivation capacity, and a retail environment where price-sensitive consumers have trained themselves to expect discounts. In states like Michigan and Oklahoma — two of the most aggressive legal markets in terms of license issuance — flower prices collapsed to levels that made large portions of the supply chain economically unsustainable.

But wholesale pricing has never been a single national market. It is fifty-plus separate regulatory environments with distinct supply-demand dynamics, licensing regimes, and consumption demographics. And the latest read on the data suggests that while the national composite number keeps declining, the distribution of outcomes underneath it is far wider than the top-line figure implies.

Some markets are holding. A few are even recovering. Others are worse than the aggregate suggests.

For operators managing multi-state footprints — and for the MSOs who built those footprints as a hedge against exactly this kind of state-level volatility — that dispersion is the real story.

Why the Average Misleads

When analysts report a national average wholesale price for cannabis flower, they’re typically pulling from a weighted composite of reported transaction data across multiple state markets. The methodology has value: it provides a directional signal, a macro-level read on whether the industry’s price floor is rising or falling.

The problem is that a company operating in, say, New Jersey and Missouri is not operating in the same wholesale market. Its cultivation economics, its retail margins, and its competitive pressure points are entirely different in each state. A national average that blends a still-constrained East Coast market with a deeply oversupplied Midwest market will tell that operator almost nothing useful about its actual position.

The same logic applies at the regional level. A multi-county operator in a limited-license state faces a different pricing reality than one operating in a mature, unlimited-license regime. The national number smooths over those differences in a way that can produce genuine strategic blind spots.

What the Regional Data Actually Shows

The picture that emerges from market-level analysis is uneven in ways that cut against simple narratives. Markets that launched with tight licensing caps have, in several cases, maintained more durable wholesale prices — not because demand is particularly strong, but because supply has been constrained enough to prevent the kind of floor-blowout seen in Oklahoma or Michigan. The regulatory architecture, it turns out, still matters enormously to pricing.

Meanwhile, newer markets — states that legalized adult use more recently and are still in the early stages of scaling commercial cultivation — are often experiencing the initial upswing of the pricing cycle that older markets went through years ago. For operators positioned in those states, wholesale economics still look healthy, at least for now.

The risk is that those operators extrapolate favorable local conditions forward without accounting for the structural dynamics that have driven prices down everywhere else: continued license expansion, increasing cultivation efficiency, and the relentless pressure from multi-state operators who can absorb margin compression in weaker markets while maintaining volume.

The cycle tends to play out the same way. The only variable is timing.

What Operators Need to Watch

For cannabis businesses making capital allocation decisions right now — expansion into new states, cultivation buildouts, wholesale contract terms — the wholesale pricing environment presents a specific kind of analytical challenge. The data exists. Market-level price reporting has improved substantially over the past two years. But aggregated national figures remain easier to find than granular state-level data, and it’s the granular data that actually matters for most operational decisions.

The operators who are navigating this well tend to be doing a few things differently. They are treating state markets as distinct analytical units, not proxies for a national trend. They are building pricing model scenarios that account for the maturation of supply in markets where they’re currently benefiting from early-stage dynamics. And they are watching license issuance rates and cultivation permit data — the leading indicators of future supply — rather than just the current price floor.

MSOs with genuine multi-state diversification have a structural advantage here: their aggregated revenue smooths out some of the state-level volatility. But that same aggregation can mask underperformance in specific markets if operators aren’t looking carefully.

The International Context

It is worth noting, briefly, that the pricing pressure affecting U.S. wholesale markets exists against a backdrop of rapid international growth in regulated cannabis. Germany imported over 218 tons of medical cannabis in a single year, cementing its position as Europe’s largest legal market and signaling sustained demand growth that U.S.-focused operators are largely not positioned to access.

The divergence between a maturing, price-compressed U.S. market and an expanding international one is a structural reality that domestic operators have mostly set aside. At some point, it becomes a more pressing strategic question — particularly for large MSOs with the capital and operational infrastructure to consider international positioning.

For now, though, the immediate concern for most U.S. operators is simpler: understanding which side of the wholesale trend their market is actually on, and making decisions accordingly. The national number will tell you which way the wind is blowing. It won’t tell you what’s happening in your backyard.

Caleb Quinn covers cannabis business, investment, and market data for CannabisInquirer.com.

Sponsored
PuffyParcel
Skip the Dispensary. Lab-Tested THCa Delivered to Your Door.
100% federally legal hemp-derived products from small U.S. growers — discreetly shipped straight to you. Free shipping on orders over $50.
Shop Now →

Responses

💬
Be the first to weigh in.
The money always tells the story. What are you seeing in your market?

Your email won't be published. Staff occasionally respond.

✓ Response submitted — it'll appear here after a quick review.
Something went wrong. Check your fields and try again.